Logo - Taiho Oncology
Search
EHA 2025
European Hematology Association
Milan, Italy
Jun 12 - Jun 15
Milan, Italy
  • Oral Presentation

    ALL-ORAL DECITABINE-CEDAZURIDINE (DEC-C) + VENETOCLAX (VEN) IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML) INELIGIBLE FOR INDUCTION CHEMOTHERAPY: PHASE 1/2 CLINICAL TRIAL RESULTS

    June 12, 2025

    Roboz G, Zeidan A, Mannis G, et al.